Rakuten Investment Management Inc. Makes New $19.71 Million Investment in Astera Labs, Inc. $ALAB

Rakuten Investment Management Inc. bought a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 43,238 shares of the company’s stock, valued at approximately $19,715,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Keating Financial Advisory Services Inc. bought a new stake in shares of Astera Labs in the second quarter worth $25,000. Transamerica Financial Advisors LLC purchased a new stake in shares of Astera Labs during the 2nd quarter valued at about $35,000. Johnson Financial Group Inc. purchased a new position in shares of Astera Labs in the second quarter worth approximately $43,000. Bell Investment Advisors Inc bought a new stake in Astera Labs during the second quarter valued at approximately $43,000. Finally, Reflection Asset Management bought a new position in Astera Labs in the fourth quarter worth approximately $25,000. 60.47% of the stock is owned by institutional investors.

Insider Transactions at Astera Labs

In related news, COO Sanjay Gajendra sold 90,630 shares of the business’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the sale, the chief operating officer directly owned 1,119,038 shares in the company, valued at approximately $380,864,583.30. The trade was a 7.49% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, General Counsel Philip Mazzara sold 6,801 shares of the company’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.50, for a total value of $2,315,740.50. Following the sale, the general counsel directly owned 96,542 shares in the company, valued at $32,872,551. This trade represents a 6.58% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders sold 419,244 shares of company stock valued at $163,135,169. 10.40% of the stock is owned by insiders.

Astera Labs Stock Performance

Shares of ALAB stock opened at $289.47 on Friday. The stock has a fifty day simple moving average of $342.38 and a two-hundred day simple moving average of $249.65. The firm has a market capitalization of $50.22 billion, a PE ratio of 143.30 and a beta of 3.84. Astera Labs, Inc. has a 52-week low of $97.89 and a 52-week high of $499.48.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. The company had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The firm’s revenue was up 104.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, sell-side analysts forecast that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Analyst Ratings Changes

Several brokerages have recently weighed in on ALAB. Royal Bank Of Canada lifted their price target on shares of Astera Labs from $425.00 to $500.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 5th. Weiss Ratings reissued a “hold (c)” rating on shares of Astera Labs in a report on Tuesday, August 18th. Jefferies Financial Group upped their price target on Astera Labs from $270.00 to $450.00 and gave the stock a “buy” rating in a research report on Wednesday, August 5th. Evercore reaffirmed an “outperform” rating and issued a $297.00 price objective on shares of Astera Labs in a research note on Tuesday, May 19th. Finally, UBS Group reaffirmed a “neutral” rating and set a $425.00 price objective on shares of Astera Labs in a research report on Wednesday, August 5th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $340.53.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.